A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants
- 28 February 1990
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 116 (2), 295-300
- https://doi.org/10.1016/s0022-3476(05)82897-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Surfactant replacement therapy in neonatal respiratory distress syndromeEuropean Journal of Pediatrics, 1988
- Severe Neonatal Respiratory Distress Syndrome Treated with the Isolated Phospholipid Fraction of Natural SurfactantActa Paediatrica, 1987
- DOUBLE-BLIND CONTROLLED TRIAL OF SINGLE-DOSE TREATMENT WITH BOVINE SURFACTANT IN SEVERE HYALINE MEMBRANE DISEASEThe Lancet, 1987
- Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.JCI Insight, 1985
- Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trialThe Journal of Pediatrics, 1985
- INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHTThe Lancet, 1985
- An International Classification of Retinopathy of PrematurityAmerican Journal of Ophthalmology, 1984
- ARTIFICIAL SURFACTANT THERAPY IN HYALINE-MEMBRANE DISEASEThe Lancet, 1980
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978